Novel daidzein molecules exhibited anti-prostate cancer activity through nuclear receptor ERβ modulation,
Animals
Caspases
/ drug effects
Cell Line, Tumor
Cell Proliferation
/ drug effects
Cell Survival
Cyclin D1
/ drug effects
Dose-Response Relationship, Drug
Estrogen Receptor beta
/ drug effects
Female
Genistein
/ pharmacology
Humans
Isoflavones
/ pharmacology
Male
Mice
Mice, Inbred C57BL
Prostatic Neoplasms
/ pathology
Rats
Rats, Sprague-Dawley
Receptors, Estrogen
/ drug effects
Tumor Burden
/ drug effects
Xenograft Model Antitumor Assays
Deoxybenzoins
anti-androgen
anticancer
caspase
estrogen receptor
receptor binding studies
Journal
Journal of chemotherapy (Florence, Italy)
ISSN: 1973-9478
Titre abrégé: J Chemother
Pays: England
ID NLM: 8907348
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
pubmed:
2
6
2021
medline:
4
2
2022
entrez:
1
6
2021
Statut:
ppublish
Résumé
Eight novel ERβ selective daidzein analogues (NCE1-8) were synthesized and their anti-cancer activity was evaluated by
Identifiants
pubmed: 34060437
doi: 10.1080/1120009X.2021.1924935
doi:
Substances chimiques
Estrogen Receptor beta
0
Isoflavones
0
Receptors, Estrogen
0
Cyclin D1
136601-57-5
daidzein
6287WC5J2L
Genistein
DH2M523P0H
Caspases
EC 3.4.22.-
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM